The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 883,055 | 5,775,000 | SH | OTR | 5,775,000 | 0 | 0 | ||
EXTENDED STAY AMER INC | UNIT 99/99/9999B | 30224P200 | 14,131 | 715,499 | SH | OTR | 715,499 | 0 | 0 | ||
PRA HEALTH SCIENCES INC | COM | 69354M108 | 53,666 | 350,000 | SH | OTR | 350,000 | 0 | 0 | ||
SLACK TECHNOLOGIES INC | COM CL A | 83088V102 | 293,645 | 7,227,300 | SH | OTR | 7,227,300 | 0 | 0 |